Bedfont Scientific Limited articles
Bedfont® Scientific Limited hosted an informative webinar Children with Asthma, with seasoned respiratory nurse Carol Stonham MBE leading the discussion along with Kirsty at Medway Asthma Self-Help (MASH). The webinar was a private screening for local Medway football coaches and gave valuable insights on managing, treating and recognising an asthma emergency.
Carol Stonham MBE, has been a registered nurse since 1986, transitioning from acute hospital settings to primary
Stoptober takes place every October in the UK. Launched in 2012, the campaign encourages smokers to quit for 28 days. The theme for 2024 is ‘When you stop smoking, good things start to happen’. Bedfont® Scientific Ltd., world leaders in breath analysis, hosted a discussion with Smokerlyzer® Medical Advisory Board Members Dr Amer Siddiq Amer Nordin and Dr Anne Yee. The panel explored the impact Stoptober has on people’s quit smoking attempts
Bedfont® Scientific Limited hosted an insightful webinar Mastering Gut Health: Understanding SIBO, Carbohydrate Malabsorption, and Accurate Gastrointestinal Investigation. Gastrointestinal Physiologist and Bedfont® Medical Advisory Board member Melissa Dooley, led the discussion and shared valuable information on various gastrointestinal disorders and the importance of not self-diagnosing.
Melissa Dooley began her career as a Gastrointestinal Physiologist
Methods of measuring FeNO
Fractional exhaled nitric oxide (FeNO) measurement plays a crucial role in the diagnosis and management of airway inflammation. FeNO testing is recommended by the National Institute for Health and Care Excellence (NICE) to help diagnose asthma1, with the NObreath® device one of three devices recommended by NICE1.
In 2005 the American Thoracic Society (ATS) and the European Respiratory Society (ERS) pub
FeNO Testing in Asthma Care
Although airway eosinophilic inflammation is a key characteristic of asthma, there are few methods available to measure it. This inflammation can be assessed by measuring eosinophils and eosinophilic cationic protein (ECP) in sputum or by measuring ECP in blood samples1. However, these methods are considered time-consuming, expensive, and not readily available.
For most asthma patients, airway inflammation is driven by an allergen-ind